INNOVATIVE LYOPHILIZED DOSAGE FORM OF BCS CLASS II DRUGS

Heena Tajir* and Dr. Indira Parab

ABSTRACT

The development of lyophilized medication delivery systems has received a lot of attention in the pharmaceutical industry. This review's objective is to give readers a thorough overview of recent revolutionary advances in the development and use of lyophilized medicine delivery systems. This article highlights some of the most recent advancements in a variety of pharmaceutical formulations for BCS Class II drugs. These include ophthalmic lyophilisate carrier system (OLCS), lyophilized orally disintegrating tablets, lyophilization of nanocapsule, lyophilized nasal inserts, and lyophilized nasal suppositories. These formulations can be used to deliver a specific dose of medication and achieve a controlled release of the active ingredient. Pharmaceutical firms are focusing on the development of extremely sophisticated and sophisticated delivery systems in order to solve or fulfill key problems such cumbersome self-injection medication administration methods, the risk of needlestick injuries, and others (lengthy dose preparation timings).

Keywords: Lyophilization, ophthalmic, Long-term stability, BCS Class II.